Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Haematologica
|
May 7, 2026
Altered immune and treatment response gene expression signatures among povertyexposed children with B-cell acute lymphoblastic leukemia
Amy Guillaumet-Adkins, Elnaz Mirzaei Mehrabad, Noori Sotudeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 16, 2017
BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee
Sarah A Holstein, Hervé Avet-Loiseau, Theresa Hahn, et al.
Angewandte Chemie (International Ed. in English)
|
May 1, 2020
On-Surface Synthesis of Cumulene-Containing Polymers via Two-Step Dehalogenative Homocoupling of Dibromomethylene-Functionalized Tribenzoazulene
José I Urgel, Marco Di Giovannantonio, Kristjan Eimre, et al.
Blood Advances
|
January 15, 2025
Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma
Johannes M Waldschmidt, Noori Sotudeh, Sankalp Arora, et al.
Science (New York, N.Y.)
|
June 30, 2012
Landscape of somatic retrotransposition in human cancers
Eunjung Lee, Rebecca Iskow, Lixing Yang, et al.
Oral Oncology
|
June 6, 2021
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma
Glenn J Hanna, Anne ONeill, Jennifer M Cutler, et al.
Science Translational Medicine
|
November 4, 2016
Genetic interrogation of circulating multiple myeloma cells at single-cell resolution
Jens G Lohr, Sora Kim, Joshua Gould, et al.
Cancer Immunology Research
|
June 27, 2022
Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy
Nam Gyu Im, Amy Guillaumet-Adkins, Megha Wal, et al.
Leukemia
|
July 31, 2025
Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma
Tayla B Heavican-Foral, Felix Korell, Irene Scarfò, et al.
Cancer Cell
|
January 18, 2014
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy
Jens G Lohr, Petar Stojanov, Scott L Carter, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Haematologica
|
May 7, 2026
Altered immune and treatment response gene expression signatures among povertyexposed children with B-cell acute lymphoblastic leukemia
Amy Guillaumet-Adkins, Elnaz Mirzaei Mehrabad, Noori Sotudeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 16, 2017
BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee
Sarah A Holstein, Hervé Avet-Loiseau, Theresa Hahn, et al.
Angewandte Chemie (International Ed. in English)
|
May 1, 2020
On-Surface Synthesis of Cumulene-Containing Polymers via Two-Step Dehalogenative Homocoupling of Dibromomethylene-Functionalized Tribenzoazulene
José I Urgel, Marco Di Giovannantonio, Kristjan Eimre, et al.
Blood Advances
|
January 15, 2025
Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma
Johannes M Waldschmidt, Noori Sotudeh, Sankalp Arora, et al.
Science (New York, N.Y.)
|
June 30, 2012
Landscape of somatic retrotransposition in human cancers
Eunjung Lee, Rebecca Iskow, Lixing Yang, et al.
Oral Oncology
|
June 6, 2021
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma
Glenn J Hanna, Anne ONeill, Jennifer M Cutler, et al.
Science Translational Medicine
|
November 4, 2016
Genetic interrogation of circulating multiple myeloma cells at single-cell resolution
Jens G Lohr, Sora Kim, Joshua Gould, et al.
Cancer Immunology Research
|
June 27, 2022
Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy
Nam Gyu Im, Amy Guillaumet-Adkins, Megha Wal, et al.
Leukemia
|
July 31, 2025
Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma
Tayla B Heavican-Foral, Felix Korell, Irene Scarfò, et al.
Cancer Cell
|
January 18, 2014
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy
Jens G Lohr, Petar Stojanov, Scott L Carter, et al.
Page
of 6